Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5092158
Max Phase: Preclinical
Molecular Formula: C17H19N3O
Molecular Weight: 281.36
Molecule Type: Unknown
Associated Items:
ID: ALA5092158
Max Phase: Preclinical
Molecular Formula: C17H19N3O
Molecular Weight: 281.36
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(NC1CCCc2c1cnn2-c1ccccc1)C1CC1
Standard InChI: InChI=1S/C17H19N3O/c21-17(12-9-10-12)19-15-7-4-8-16-14(15)11-18-20(16)13-5-2-1-3-6-13/h1-3,5-6,11-12,15H,4,7-10H2,(H,19,21)
Standard InChI Key: PALKBGQMXWCZHA-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 281.36 | Molecular Weight (Monoisotopic): 281.1528 | AlogP: 2.78 | #Rotatable Bonds: 3 |
Polar Surface Area: 46.92 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 1.77 | CX LogP: 2.54 | CX LogD: 2.54 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.94 | Np Likeness Score: -1.82 |
1. Cantini N, Crocetti L, Guerrini G, Vergelli C, Schepetkin IA, Pallecchi M, Bartolucci G, Quinn MT, Teodori E, Giovannoni MP.. (2021) 1,5,6,7-Tetrahydro-4H-indazol-4-ones as human neutrophil elastase (HNE) inhibitors., 52 [PMID:34563669] [10.1016/j.bmcl.2021.128380] |
Source(1):